Javier Muñoz, Julio C. Chavez, Jason Westin, Emmanuel Bachy, Daniel Morillo, Judit Meszaros Joergensen, Guilherme Fleury Perini, Abel Costa, Parth Rao, Niloufar Marsousi, Gang Yang, Akshay Sudhindra, Michael Pourdehnad, Soraya Carrancio-Anton, Jessica Voestch, Serena K. Perna, Jean-Marie Michot. "Golcadomide (GOLCA), a potential, first-in-class, oral CELMoD ± rituximab (R) in patients (pts) with relapsed/refractory (R/R) follicular lymphoma (FL): Long-term follow-up (f/u) of the phase (Ph) 1/2 CC-99282-NHL-001 study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e19046